Aprogen Biologics Revenue

In the year 2025, Aprogen Biologics had annual revenue of 73.23B KRW with 8.68% growth. Aprogen Biologics had revenue of 20.36B in the quarter ending December 31, 2025, a decrease of -7.64%.

Revenue

73.23B

Revenue Growth

+8.68%

P/S Ratio

0.68

Revenue / Employee

187.28M

Employees

391

Market Cap

49.59B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	73.23B	5.85B	8.68%
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
MYUNGMOON Pharm co.,Ltd	195.25B
Yuyu Pharma	140.88B
Enzychem Lifesciences	67.75B
Kukje Pharma	175.50B
Dong Sung Bio Pharm.Co.,Ltd.	78.44B
CKD Bio	159.93B
Ildong Holdings	590.89B
HANDOK	535.14B

Revenue Rankings